PolyPid Correlations

PYPD Stock  USD 2.96  0.11  3.58%   
The current 90-days correlation between PolyPid and Cue Biopharma is 0.04 (i.e., Significant diversification). The correlation of PolyPid is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

PolyPid Correlation With Market

Average diversification

The correlation between PolyPid and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

Moving against PolyPid Stock

  0.31DNTH Dianthus Therapeutics Earnings Call TodayPairCorr
  0.45VRTX Vertex PharmaceuticalsPairCorr
  0.33CDTTW Conduit PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
INMBANIX
INABCUE
INMBCUE
ANEBCUE
ANEBINAB
ANIXCUE
  
High negative correlations   
ANEBANIX
INABANIX
INABINMB
ANEBINMB
ANEBANGN
ANEBNAVB

Risk-Adjusted Indicators

There is a big difference between PolyPid Stock performing well and PolyPid Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PolyPid's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CUE  4.90  0.01  0.00 (0.08) 0.00 
 8.51 
 38.78 
ANIX  3.38  0.23  0.05  0.09  3.74 
 7.14 
 26.44 
INMB  4.63  0.78  0.16  1.01  4.50 
 12.57 
 28.67 
INAB  4.99 (0.32) 0.00 (0.52) 0.00 
 11.54 
 32.12 
EFTR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LABP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
APGN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NAVB  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANGN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANEB  5.11  0.40  0.06  0.18  5.31 
 19.58 
 40.87 

PolyPid Corporate Management

Ori WarshavskyChief USProfile
Dikla AkselbradChief OfficerProfile
Malka ReichartScientific DirectorProfile
Rivi LevariVice ResourceProfile
Orna BlumLegal CounselProfile
JeanMarc PharmDChief OfficerProfile
Tal VilnaiGeneral SecretaryProfile